Available online on 15.10.2026 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2026 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
Isolation of two cassane-type diterpenoids from the root bark of Erythrophleum ivorense A. Chev. (Fabaceae)
Richmond Jean-François Kablan 1*, Aka Faustin Kabran 2, Ahmont Landry Claude Kablan 1, Dibi Jacques Konan 3, Yaya Camara 1, Koffi Barthélemy Attioua 2
1 Laboratoire Environnement, Climat, Santé, Ingénierie et Développement Durable, Département de Mathématiques-Physique-Chimie, UFR des Sciences Biologiques, Université Peleforo GON COULIBALY, BP 1328 Korhogo, Côte d'Ivoire.
2 Laboratoire de Constitution et Réaction de la Matière, UFR SSMT, Université Félix HOUPHOUËT-BOIGNY, 22 BP 582 Abidjan 22, Côte d'Ivoire.
3 Laboratoire de Chimie BioOrganique et de Substances Naturelles (LCBOSN), UFR Sciences Fondamentales et Appliquées, Université Nangui ABROGOUA, 02 BP 0801 Abidjan 02, Côte d'Ivoire.
|
Article Info: _____________________________________________Article History: Received 11 July 2026 Reviewed 20 Aug 2026 Accepted 13 Sep 2026 Published 15 Oct 2026 _____________________________________________ Cite this article as: Kablan RJF, Kabran AF, Kablan ALC, Konan DJ, Camara Y, Attioua KB, Isolation of two cassane-type diterpenoids from the root bark of Erythrophleum ivorense A. Chev. (Fabaceae), Journal of Drug Delivery and Therapeutics. 2026; 16(10):1-6 DOI: https://doi.org/10.22270/jddt.v16i10.8014 ____________________________________________ For Correspondence: Kablan Richmond Jean-François, Laboratoire Environnement, Climat, Santé, Ingénierie et Développement Durable, Département de Mathématiques-Physique-Chimie, UFR des Sciences Biologiques, Université Peleforo GON COULIBALY, BP 1328 Korhogo, Côte d'Ivoire. |
Abstract _________________________________________________________________________________________________________________ Erythrophleum ivorense is a large tree found in the tropical forests of Africa, used to treat certain skin conditions or injuries. This plant species is known for its high content of cassane-type diterpenoids, compounds known for their diverse biological activity. Extraction by maceration in ethanol was followed by successive purifications via silica gel column chromatography, Sephadex® LH-20 gel and preparative HPLC-UV. Structural determination was carried out on the basis of comprehensive spectroscopic data, including one- and two-dimensional nuclear magnetic resonance (¹H, ¹³C, COSY, HSQC, HMBC, NOESY) as well as high-resolution mass spectrometry (HR-ESI-MS). Two cassane-type diterpenoids, namely erythroivorensin and erythrodine, were isolated. The results confirm that cassane-type diterpenoids are chemotaxonomic markers of the genus Erythrophleum. Keywords: Erythrophleum ivorense, cassane-type diterpenoids, erythroivorensin, erythrodine, NMR.
|
INTRODUCTION
The genus Erythrophleum (family Fabaceae, subfamily Caesalpinioideae) comprises several species of tropical trees widely distributed in sub-Saharan Africa1-5, Asia6-8, and Australia9-11. Species of the genus Erythrophleum have been used as digitalis-like drugs due to their various effects on the heart. Medicinal plants of this genus also show good results when used as tonics and blood circulation stimulants, as well as emetics, anesthetics, anthelmintics, antimalarials, analgesics, disinfectants, and for treating dermatitis, convulsions, inflammations, heart disorders, venom poisoning, headaches, edema, gangrenous wounds, and rheumatism. This article presents an overview of isolated compounds of this kind, along with their biological evaluations. The bibliographic sources used for this article come from the literature published from the 1960s to the present12.
The genus Erythrophleum contains diverse classes of compounds, including alkaloids, terpenoids, phytosterols, saponins, flavonoids, and their derived glycosides. Numerous in vitro and in vivo pharmacological results, such as cytotoxicity, antioxidant, antibacterial, anticonvulsant, anti-inflammatory, anticancer, anti-angiogenic, sedative, cardiac, and other toxic activities, indicate that extracts, fractions, and isolated compounds from Erythrophleum species can be valuable resources for the development of new natural medicines. Phytochemically, Erythrophleum is characterized by an abundance of cassan-type diterpenoids with nitrogenous (amine and amide) or non-nitrogenous functional groups. These secondary metabolites possess a fused perhydrophenanthrenic tricyclic skeleton and exhibit a broad spectrum of biological activities: regulation of cardiac inotropy, anti-inflammatory, antimicrobial activities and strong cytotoxicity towards multiple tumor cell lines11.
Among them, Erythrophleum ivorense A. Chev . (known as Tali) is traditionally used in African folk medicine to treat various ailments (pain, skin infections, parasites) and has historically been used as a trial and ambush poison due to its high toxicity13,14.
Although the trunk bark of E. ivorense has been the subject of several studies isolating major compounds such as cassain and cassaidin, the root bark remains a less explored plant matrix, potentially rich in novel minor derivatives. The objective of this study is to isolate and elucidate the structure of two new diterpenoids, non-nitrogenous cassanes from root bark: erythroivorensin and erythrodine.
1. MATERIALS AND METHODS
1.1. Equipment
1.1.1. Plant material
The root bark of E. ivorense (Fabaceae) was collected in Agboville, southern Côte d'Ivoire, in December 2024. It was identified and authenticated at the National Floristic Center of Félix Houphouët-Boigny University. The bark of roots growing above ground was scraped with a machete, dried in the laboratory in the shade, and ground using an electric grinder. The resulting powder was used for the extractions.
1.1.2. Technical Equipment
MassHunter software (Agilent Technologies) was used for the acquisition and analysis of spectrometric data obtained by high-performance liquid chromatography coupled with electrospray ionization mass spectrometry (HPLC-ESI-MS). The analyses were performed using an Agilent Quadrupole Time-of-Flight (Q-TOF) mass spectrometer, specifically a Q-TOF 6200 (TOF Series/6500 Series Q-TOF, software version B.08.00, build B8058.0).
1.2. Methods
1.2.1. Extraction
Erythrophleum ivorense root bark (700 g) was pulverized and then subjected to solid-liquid extractions at room temperature. This operation was performed three times over 24 hours in distilled ethanol (7 L). After filtration, the different solutions were evaporated using a rotary evaporator (Rotavapor, Sartorius Stedim Biotech), then dried to give 34.3 g of crude extract. A portion of this ethanolic extract (15 g) was dissolved in 50 mL of MeOH, then alkalized with a few drops of NH4OH (25%), and then made up to 100 mL of CH2Cl2. To the resulting solution, 100 mL of 1% sulfuric acid was added, and then it was counter-extracted with distilled CH2Cl2 (100 mL x 4) to give, after evaporation under reduced pressure, the dichloromethane extract (ESD). The supernatant phase was first alkalized with NH4OH at pH 10, then counter-extracted with distilled AcOEt (100 mL x 4) to give, after evaporation using a rotary evaporator, the ethyl acetate extract (ESA). The aqueous phase is dried to give the aqueous extract (EAq).
1.2.2. Thin-layer chromatography (TLC)
Thin-layer chromatography analyses were performed on aluminum plates (Silicagel 60 F254, Merck, Germany). After development in glass tanks, the plates were observed under ultraviolet light (254 nm and 366 nm). The UV lamp used was a Vilber LourmatTM (230 V, 50 Hz, France).
1.2.3. Flash chromatography
A device with an isocratic and gradient pumping system, equipped with a double-piston pump was used. The 330 g, 120 g, and 24 g cartridges from the Grace Resolv® Silica Flash Silica series were used. These cartridges have the advantage of effectively replacing glass columns.
1.2.4. Silica gel column chromatography (CC)
Chromatographic column separations were performed taking into account the mass of the sample (fraction or extract) to be fractionated and its chromatographic profile (TLC). The column diameter and height were determined based on the sample mass. Indeed, for good separation, the mass of silica in the column is equal to 10 times the mass of the sample to be purified7. In this study, the stationary phase used in the various TLC separations was silica gel 60 (40–63 µm, Chromagel, Merck).
1.2.5. Infrared (IR) Spectrometry
The infrared spectra of our samples were recorded on a Perkin Elmer type 257 spectrometer. The samples were dissolved in MeOH or in CHCl3. The liquid is deposited between two pellets of single-crystal sodium chloride (NaCl).
1.2.6. Mass Spectrometry (MS)
Mass spectra of the isolated compounds were obtained by electrospray in positive mode on an Agilent 6530 Q-TOF-MS mass spectrometer equipped with an ESI source. The samples were dissolved in analytical-grade methanol (HPLC).
1.2.7. Analysis of compounds by nuclear magnetic resonance (NMR)
Spectra were recorded on a Brüker Avance 3 HD 400 spectrometer (1H, 400 MHz; 13C, 100 MHz), equipped with a direct multinuclear probe with gradients, an inverse multinuclear probe with gradients, an HF probe, a 1.7 mm H, C, N microprobe, and a 25-sample autosampler. Chemical shifts are expressed in ppm (parts per million) using TMS (tetramethylsilane) as the chemical shift reference. Coupling constants (J) are expressed in Hertz (Hz). The standard pulse sequence programs provided by Brüker were used to perform the two-dimensional experiments: COSY (2JH-H, 3JH-H), HSQC (1JC-H), HMBC (2JC-H, 3JC-H, and 4JC-H), and NOESY.
1.2.8. Fractionation and purification of the constituents of the ESD extract
The 2.15 g methylene chloride extract (ESD) was fractionated by flash chromatography using a cartridge containing 10 g of silica gel. Elution was carried out in a MeOH/CH2Cl2 mixture following an elution gradient of 0:100 to 50:50, v/v. Fractions G1, G2, and G3 were retained based on their TLC profiles. These fractions were then purified by HPLC. Fraction G1 was purified using the H2O + 0.1% HCOOH/ACN system (80:20 to 50:50, v/v) to obtain compound ESD2. Fraction G2 was purified using the H2O + 0.1% HCOOH/ACN system (80:20 to 20:80, v/v) to obtain compound ESD4.
2. RESULTS AND DISCUSSION
2.1. Results
2.1.1. Structural elucidation of ESD2
The compound (ESD2) was obtained as a white, amorphous solid soluble in methanol. Its IR spectrum shows the absorption band of the OH bond of the carboxylic acid at a maximum frequency of 3289 cm⁻¹, that of the C=O bond of the a,bunsaturated carboxylic acid at a maximum frequency of 1696 cm⁻¹, and the vibrations followed by stretching of the CH bond of the methyl (CH3) and methylene (CH2) groups at maximum frequencies of 2945, 2922, and 2867 cm⁻¹.The C=C double bonds give absorption bands at maximum frequencies of 1690, 1633, and 1594 cm⁻¹. The HRESI-QTOF-MS+ of the ESD2 compound indicates the peak of the pseudomolecular ion [M+H]+ at m/z 303.2321, resulting in a molecular mass of 302.2243 g/mol. This value corresponds to the empirical formula C20H30O2 (calculated mass 302.2246). 1H and 13C NMR spectra were obtained in deuterated methanol. The presence of an a,b unsaturated carboxylic acid group is confirmed by the 13C NMR peak at 174.2 ppm. The general shape of the proton and carbon-13 spectra suggests the presence of a compound with three polysubstituted rings, as in the case of cassanes diterpenes. Comparison of the spectral data of ESD2 with those in the literature allowed it to be identified as a known molecule: cassan-13,15-diene-17-oic acid or erythroivorensin (Figure 1). This molecule was previously isolated from the seeds of the species E. ivorense by Armah et al.4 but not from root bark. The chemical shift assignments are given in Table I.
Figure 1: Structure of erythroivorensin
Table I: NMR chemical shift of compound ESD2 (MeOD)
|
Atom number |
δ13C (ppm) |
δ1H (ppm; m; J, Hz) |
COSY 1JH-H |
HMBC |
NOESY |
|
1 |
39.8 |
1.79 (1H; d; 12.7); 0.9 (1H; m) |
H-2 |
H-3; H-5; H-20 |
- |
|
2 |
19.9 |
1.49 (1H; m); 1.66 (1H; d; 12.5) |
H-1; H-3 |
- |
- |
|
3 |
43.3 |
1.21 (1H; m); 1.43 (1H; m) |
H-2 |
H-1; H-5; H-18, H-19 |
- |
|
4 |
34.2 |
- |
- |
H-2; H-6 |
- |
|
5 |
56.7 |
0.94 (1H; m) |
H-6 |
H-3; H-7; H-9; H-18; H-19; H-20 |
H-9; H-18 |
|
6 |
23.0 |
1.39 (1H; m); 1.71 (1H; m) |
H-5 |
H-8 |
- |
|
7 |
33.1 |
1.09 (1H; m); 1.95 (1H; m) |
H-6; H-8 |
H-5; H-9 |
- |
|
8 |
38.6 |
2.42 (1H; m) |
H-7; H-9 |
H-6; H-11 |
H-19; H-20 |
|
9 |
54.5 |
0.95 (1H; m) |
H-8; H-11 |
H-5; H-7; H-12; H-20 |
H-5; H-18 |
|
10 |
37.9 |
- |
- |
H-2; H-8; H-11 |
- |
|
11 |
22.0 |
1.15 (1H; m); 1.88 (1H; m) |
H-9; H-12 |
H-8 |
- |
|
12 |
26.6 |
2.15 (1H; m); 2.45 (1H; m) |
H-11 |
H-9 |
- |
|
13 |
138.6 |
- |
- |
H-8; H-11; H-16 |
- |
|
14 |
134.2 |
- |
- |
H-7; H-9; H-12; H-15 |
|
|
15 |
136.6 |
6.72 (1H; dd; 17.2; 11.0) |
H-16 |
H-12 |
- |
|
16 |
114.2 |
5.07 (1H; d; 11.0); 5.28 (1H; d; 17.2) |
H-15 |
- |
- |
|
17 |
174.2 |
- |
- |
H-8 |
- |
|
18 |
33.9 |
0.87 (3H; s) |
- |
H-3; H-5, H-19 |
H-5; H-9 |
|
19 |
22.1 |
0.87 (3H; s) |
- |
H-3; H-5; H-18 |
H-8; H-20 |
|
20 |
14.6 |
0.90 (3H; s) |
- |
H-1; H-5; H-9 |
H-8; H-19 |
2.1.2. Structural elucidation of ESD4
The compound ESD4 was obtained as an amorphous solid and is soluble in methylene chloride. Its HRESI-QTOF-MS+ indicates the peak of the pseudomolecular ion [M+H]+ at m/z 301.2130, resulting in a molecular mass of 300.2052 g/mol. This value corresponds to the empirical formula C20H28O2 (calculated mass 300.2089). Its IR spectrum indicates the presence of a single carbonyl group across the absorption band at μmax 1730 cm⁻¹. The methyl (CH3) and methylene (CH2) groups give absorption bands at μmax 2947, 2922, and 2844 cm⁻¹. Unlike all the compounds we analyzed, ESD4 is the only one for which ¹H and ¹³C NMR spectra were obtained in deuterated chloroform (this molecule not being soluble in methanol). This suggests that it probably does not have a free OH group in its structure. Its NMR spectra are similar to those of compound ESD2. Indeed, the ¹³C NMR spectrum shows the presence of two double bonds (C=C) with peaks at dC 134.6 and 136.4. At 134.9 and 115.5 ppm, and on the proton spectrum, the signals concentrated in the dH range of 0.8–2.017 ppm indicate the presence of protons (CH3, CH2, and CH) carried by a system with at least three rings. The carbonyl at d 174.7 ppm (C=O) belongs to an ester group, and the alcohol portion of this ester gives the peak at 79.1 ppm (HC-O). On the HSQC spectrum, the proton at d 3.20 ppm is found to be carried by this carbon. The HMBC spectrum of ESD4 shows that this carbon at d 79.1 ppm correlates in 2JCH with the protons at d 1.68 ppm (H-6 a), 1.38 ppm (H-6 b), and 2.47 ppm (H-8). Also, the carbonyl at d 174.7 ppm correlates in 3JCH with the protons at d 3.20 ppm (H-7) and 2.47 ppm (H-8). These correlations allowed the ester group to be attached to the carbon chain. The stereochemistry of this molecule was established using correlations observed in the NOESY spectrum. Indeed, proton H-7 (dH 3.20) correlates with protons H-5 (dH 0.89), H-9 (dH 0.96), and H-18 (dH 0.84), which are behind the plane; it is therefore deduced that it is also in the same plane. Based on the above analyses, the compound ESD4 was formally identified as cassan-15-ene- [ 7,17]-γ-lactone, or erythrodine (Figure 2). This structure is isolated for the first time in Erythrophleum ivorense. The chemical shift assignments are given in Table II.
Figure 2: Structure of Cassan-15-ene- [7,17]-γ-lactone or Erythrodine
Table II: NMR chemical shift of compound ESD4 (CDCl3)
|
Atom number |
δ13C (ppm) |
δ1H (ppm; m; J, Hz) |
COSY 1JH-H |
HMBC |
NOESY |
|
1 |
38.6 |
1.78 (1H; d; 12.7); 0.92 (1H; m) |
H-2 |
H-3; H-5; H-20 |
- |
|
2 |
19.0 |
1.46 (1H; m); 1.60 (1H; d; 12.5) |
H-1; H-3 |
- |
- |
|
3 |
42.2 |
1.16 (1H; m); 1.41 (1H; m) |
H-2 |
H-1; H-5; H-18, H-19 |
- |
|
4 |
33.3 |
- |
- |
H-2; H-6 |
- |
|
5 |
55.4 |
0.89 (1H; m) |
H-6 |
H-3; H-7; H-9; H-18; H-19; H-20 |
H-7; H-9; H-18 |
|
6 |
21.8 |
1.38 (1H; m); 1.68 (1H; m) |
H-5 |
H-8 |
- |
|
7 |
79.1 |
3.20 (1H; m) |
H-6; H-8 |
H-5; H-9 |
H-5; H-9; H-18 |
|
8 |
37.4 |
2.47 (1H; m) |
H-7; H-9 |
H-6; H-11 |
H-19; H-20 |
|
9 |
52.9 |
0.96 (1H; m) |
H-8; H-11 |
H-5; H-7; H-12; H-20 |
H-5; H-7; H-18 |
|
10 |
36.8 |
- |
- |
H-2; H-8; H-11 |
- |
|
11 |
21.8 |
1.15 (1H; m); 1.84 (1H; dd; 12.6; 5.1) |
H-9; H-12 |
H-8 |
- |
|
12 |
26.1 |
2.16 (1H; m); 2.45 (1H; d; 12.3) |
H-11 |
H-9 |
- |
|
13 |
136.4 |
- |
- |
H-8; H-11; H-16 |
- |
|
14 |
134.6 |
- |
- |
H-7; H-9; H-12; H-15 |
|
|
15 |
134.9 |
6.83 (1H; dd; 17.3; 11.2) |
H-16 |
H-12 |
- |
|
16 |
115.5 |
5.15 (1H; d; 11.2); 5.33 (1H; d; 17.3) |
H-15 |
- |
- |
|
17 |
174.7 |
- |
- |
H-7; H-8 |
- |
|
18 |
33.2 |
0.84 (3H; s) |
- |
H-3; H-5, H-19 |
H-5; H-7; H-9 |
|
19 |
21.5 |
0.83 (3H; s) |
- |
H-3; H-5; H-18 |
H-8; H-20 |
|
20 |
14.9 |
0.87 (3H; s) |
- |
H-1; H-5; H-9 |
H-8; H-19 |
2.2. Discussion
Phytochemical analysis of Erythrophleum ivorense A. Chev. root bark led to the purification and isolation of erythroivorensin and erythrodine. Although these two cassane-type diterpenoids had previously been isolated from the root barks of a related species, Erythrophleum suaveolens (Guill. & Perr.) Brenan this is the first isolation from the root bark of E. ivorense. It confirms the close phylogenetic and metabolic relationship between E. ivorense and E. suaveolens, two major species of the genus Erythrophleum in Africa15-20. It demonstrates that the biosynthetic pathway of cassanic diterpenes (particularly derivatives functionalized at the A/B nuclei and the C-13 ester chain) is conserved within the root system of these two taxa. It highlights that the chemical profile of E. ivorense root bark shares key biomarkers with other members of the genus Erythrophleum, while also paving the way for the search for species-specific quantitative or stereochemical variations.
Cassane-type diterpenes of the genus Erythrophleum share structural similarities with cardenolides, notably their ability to inhibit the Na+/K+-ATPase pump. Comparison of the biological activity of erythroivorensin and erythrodine suggests that:
The presence of an amino or amidated group on the side chain significantly increases affinity for membrane receptors. The degree of hydroxylation on the tricyclic ring plays a crucial role in modulating selective cytotoxicity against tumor cells.
3. CONCLUSION
The phytochemical study carried out on the root bark of Erythrophleum ivorense enabled the purification and complete structural characterization of two cassane-type diterpenoids: erythroivorensin and erythrodine. The combined use of modern chromatographic techniques and high-resolution multidimensional NMR spectroscopy ensured the elucidation of their structures and relative stereochemistry. These results enrich the chemotaxonomy of the genus Erythrophleum and confirm the underestimated molecular diversity of the underground parts of this plant. Further in vitro and in vivo pharmacological evaluations are planned to clarify the cytotoxic mechanisms of action and assess the therapeutic potential of these molecules as lead compounds in anticancer or cardiotonic pharmacology.
Acknowledgement: The authors wish to express their profound gratitude to Mr. TERE Henri for the collection of the plants. They also thank the staff of UFR SSMT at Université Félix HOUPHOUËT-BOIGNY for their technical support, as well as the inhabitants of the Agboville region, whose ethnobotanical knowledge proved to be of great richness.
Conflict of Interest: The authors declare that they have no conflict of interest in relation to this manuscript.
REFERENCES
1. Kablan ALC, Konan JD, Komlaga G, Kabran FA, Ballo D, N'Tamon AD, Kouamé T, Jagora A, Leblanc K, Seon-Méniel B, Benidder MA, Attioua KB, Le Pogam P, Champy P. Five new cassane diterpenes from the seeds and bark of Erythrophleum suaveolens. Fitoterapia. 2020; 147:104700. https://doi.org/10.1016/j.fitote.2020.104700 PMid:32763366
2. Kablan ALC, Kabran AF, Attioua KB, Konan DJ, Sissouma D, Seon-Meniel B, Leblanc K, Champy P. Chemical study of the seeds of Erythrophleum ivorense A. Chev. (Fabaceae). Biochem Syst Ecol. 2020; 91:104059. https://doi.org/10.1016/j.bse.2020.104059
3. Du D, Qu J, Yu S, Ma S, Lv H, Liu J, Liu Y, Wang J, Wang X. Oleanane-type triterpene saponins and cassaine-type diterpenoids from Erythrophleum fordii. Planta Med. 2011; 77:1631-1638. https://doi.org/10.1055/s-0030-1270992 PMid:21484673
4. Armah FA, Annan K, Mensah AY, Amponsah IK, Tocher DA, Habtemariam S. Erythroivorensin: a novel anti-inflammatory diterpene from the root-bark of Erythrophleum ivorense (A Chev). Fitoterapia. 2015; 105:37-42. https://doi.org/10.1016/j.fitote.2015.06.001 PMid:26057191
5. Armah FA, Amponsah IK, Mensah AY, Dickson RA, Steenkamp PA, Madala NE, Adokoh CK. Leishmanicidal activity of the root bark of Erythrophleum ivorense (Fabaceae) and identification of some of its compounds by ultra-performance liquid chromatography quadrupole time of flight mass spectrometry (UPLC-QTOF-MS/MS). J Ethnopharmacol. 2018; 211:207-216. https://doi.org/10.1016/j.jep.2017.09.030 PMid:28970156
6. Du D, Qu J, Wang JM, Yu SS, Chen XG, Xu S, et al. Cytotoxic cassaine diterpenoid-diterpenoid amide dimers and diterpenoid amides from the leaves of Erythrophleum fordii. Phytochemistry. 2010; 71:1749-1755. https://doi.org/10.1016/j.phytochem.2010.07.004 PMid:20678783
7. Konan JD, Attioua KB, Kablan ALC, Kabran AF, Koffi AA, Aka Any-Grah S, Sissouma D, Seon-Meniel B, LeBlanc K, Jullian JC, Beniddir MA. New cassane diterpenoids from the root bark of Erythrophleum suaveolens. Phytochem Lett. 2019; 31:166-169. https://doi.org/10.1016/j.phytol.2019.04.001
8. Konan DJ, Attioua KB, Kablan ALC, Kabran AF, Koua KBD, Okpekon AT, Aka Any-Grah S, Sissouma D, Koffi AA. Evaluation of antioxidant activities of methanol extracts and cassane diterpenoids from Erythrophleum suaveolens (Guill. and Perr.) Brenan (Fabaceae). J Pharmacogn Phytochem. 2019; 8(3):1051-1055.
9. Konan JD, Attioua BK, Kabran AF, Kablan ALC, Koffi AA, Aka Any-Grah S, Sissouma D, Seon-Meniel B, Karine L, Jullian JC, Beniddir MA, Champy P. Spectroscopic data of new cassane diterpenoids from the root bark of Erythrophleum suaveolens. Data Brief. 2019; 25:104315. https://doi.org/10.1016/j.dib.2019.104315 PMid:31453295 PMCid:PMC6700417
10. Konan JD, Kabran FA, Attioua BK, Kablan ALC, Aka AGS, Koffi AA, Akoubet O, Otogo NE, Seon-Meniel B, Le Blanc K, Jullian JC, Sissouma D, Beniddir MB, Champy P. Three novel non-nitrogenous cassane diterpenoids from Erythrophleum suaveolens (Guill. and Perr.) Brenan (Fabaceae). Nat Prod Res. 2019; 35:1364-1371. https://doi.org/10.1080/14786419.2019.1650354 PMid:31389269
11. Son NT. Genus Erythrophleum: botanical description, traditional use, phytochemistry and pharmacology. Phytochem Rev. 2019; 18:571-599. https://doi.org/10.1007/s11101-019-09640-0
12. Anaïs-Pasiphaé G, Adeline F, Jean-Louis D. Ecology and management of multi-use species of the genus Erythrophleum (Fabaceae-Caesalpinioideae) in Africa (literature review). Biotechnol Agron Soc Environ. 2015; 19(4):415-429.
13. Adebiyi O, Ajayi O, Olopade F. Neurotoxicity and behavioral alterations following subchronic administration of aqueous extract of Erythrophleum ivorense stem bark in mice. Basic Clin Neurosci. 2021; 12(5):629-638. https://doi.org/10.32598/bcn.2021.1057.2 PMid:35173917 PMCid:PMC8818113
14. Anning AS, Kwakye-Nuako G, Ameyaw EO, Mosore MT, Asare KK. In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana. Access Microbiol. 2019; 1(7):e000050. https://doi.org/10.1099/acmi.0.000050 PMid:32974542 PMCid:PMC7481739
15. Anaïs-Pasiphaé G, Adeline F, Jean-Louis D. Ecology and management of multi-use species of the genus Erythrophleum (Fabaceae-Caesalpinioideae) in Africa (literature review). Biotechnol Agron Soc Environ. 2015; 19(4):415-429.
16. Kablan ALC, Dade JME, Say M, Okpekon TA, Yapo KD, Ouffouet SK, Koffi AP, Retailleau P, Champy P. Four new cassane diterpenoid amides from Erythrophleum suaveolens (Guill and Perr.) Brenan. Phytochem Lett. 2014; 10:60-64. https://doi.org/10.1016/j.phytol.2014.08.005
17. Dade JME, Kablan ALC, Say M, Okpekon TA, Yapo KD, Komlaga G, Boti JB, Koffi AP, Guei LE, Djakouré LA, Champy P. Cassane diterpenoids stem bark of Erythrophleum suaveolens (Guill. and Perr.) Brenan. Phytochem Lett. 2015; 12:224-231. https://doi.org/10.1016/j.phytol.2015.04.002
18. Adu-Amoah L, Kesseih E, Agyare C, Hensel A. Antimicrobial and cytotoxicity studies of the methanolic extracts of Erythrophleum ivorense leaf and stem bark. Planta Med. 2013; 79(13):1153-1157. https://doi.org/10.1055/s-0033-1351995
19. Cronlund A. Two new alkaloids from the bark of Erythrophleum ivoirense. Acta Pharm Suec. 1973; 10:507-514.
20. Cronlund A. New alkaloids from Erythrophleum species. Planta Med. 1973; 24:371-374. https://doi.org/10.1055/s-0028-1099511 PMid:4789559